Tomorrow Biostasis is a Europe based cryonics provider which is increasing their presence also in USA and globally.

Come to the free online presentation for updates about the US path, what happens and where it is going. The presentation will be straightforward with a time for your questions.

https://luma.com/cykttgy2

Founders of the cryonics provider Tomorrow Biostasis will answer your questions, including the not most serious ones 😜

Join for free 👇 https://luma.com/event/evt-F4ukXBilgGL5zD0

Ask quotations in advance 👇 https://app.sli.do/event/jMPA1Ld1E9vXb9hDwe5NNj/live/questions

A free, virtual live event where the Europe based cryonics provider Tomorrow Biostasis will present their approach to quality of cryopreservation.

What they measure, how they operate, and much more!

Sign up here: buff.ly/sWVVYgt

https://www.synapseconclave.com/india

Emil Kendziorra, the co-founder and CEO of cryonics provider Tomorrow Biostasis, presents report on quality of Tomorrow Bio's cryopreservation cases done in 2025.

Some important highlights:

• why public quality reports matter
• the mindset about handling issues during cryopreservation
• quality of cases in USA in particular
• recalibration on CT scanes based on pig tests
• electron microscopy quality tests of vitrified brain tissue (more in a dedicated webinar)
• big change on 18th February 2026
• Q&A

Tim Gibson, from Cryonics UK, talks about his experiences with hospital, coroners, government agencies, and families of people to be put into biostasis.

I found this ambulance not by a chance but during my visit in the office out Tomorrow Biostasis, a cryonics provider based in Europe. But, still, I was surprised to see it just causally be parked on the street and be able to see inside. They have clearly put a lot of attention into making it a great tool for field cryoprotection.

Membership payments cover costs of running the organisation of the provider, stand-by teams and improvements.

They are distinct from cost for actual preservation.

Tomorrow Biostasis, a cryonics providers in Europe and parts of North America, enables options for monthly small payments and one-time big payment of 9 999 €.

On 1st February 2026, the cost of one-time payment is going to permanently increase to 15 000 €.

If you have already decided for cryonics and have elected Tomorrow Biostasis and their one-time payment, it may be a good idea to pay rather sooner than later (and more costly).

If you haven't decided yet for provider or even whether cryopreservation is good fit for you, you may contact providers in your area and ask them for a consultation.

A new study shows that significant part of USA physicians are knowledgeable, comfortable and supportive of cryopreservation as an end-of-life decision.

The full pre-print 👇 https://www.medrxiv.org/content/10.64898/2025.12.03.25341583v1.full

Tomorrow Biostasis, cryonics provider in Europe and parts of North America, will present a report on its cases in 2025. How it went operationaly, what is the quality and more.

Join for free 👇 https://luma.com/ubbgp3ln

A new highly intrinsically motivated employee is wanted for a biostasis company for a position in Florida.

See more info 👇 https://join.com/companies/tomorrowbiostasis/15353987-leadership-cxo-position-in-unique-biotech

(I do not know more details, I just relay the message here)

If you sign for cryopreservation at Tomorrow Biostasis in December 2025 and use the code 𝗠𝗘𝗥𝗥𝗬𝟮𝟬𝟮𝟱 at checkout, you will get 1st year totally free while still being a full right member.

https://www.tomorrow.bio/

(I am not affiliated with them)

User the code LAST50 at signup. https://member.tomorrow.bio/v2/signup/1/

(I am not affiliated to TB. I just support them and cryo field.)

cross-posted from: https://lemmy.world/post/33768012

The world’s “oldest baby” has been born in the US from an embryo that was frozen in 1994, it has been reported.

Thaddeus Daniel Pierce was born on 26 July in Ohio to Lindsey and Tim Pierce, using an “adopted” embryo from Linda Archerd, 62, from more than 30 years ago.

In the early 1990s, Archerd and her then husband decided to try in vitro fertilisation (IVF) after struggling to become pregnant. In 1994 four embryos resulted: one was transferred to Archerd and resulted in the birth of a daughter, who is now 30 and mother to a 10-year-old. The other embryos were cryopreserved and stored.

“We didn’t go into it thinking we would break any records,” Lindsey told the MIT Technology Review, which first reported the story. “We just wanted to have a baby.”

Tomorrow Bio, a leading European (starting with presence also in North America) cryopreservation provider had an hybrid event in its site in Switzerland. Here is 3,5 hours recording from it. Enjoy.